Don't Exaggerate

UCLA researcher Christina Agapakis writes at The Crux blog that "exuberant over-optimism about the possibilities of genetics, both sequencing and now synthesizing genes, has created outsized expectations of what DNA can do, blurring the lines between science fiction and science fact." Scientific "hype," particularly the excitement currently surrounding synthetic biology and "biohacking," is exaggerating the possibilities and providing an unreali

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.